| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |